Sleep Disorders Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who have not experienced withdrawal symptoms in the past 2 weeks
- People who are currently stabilised on buprenorphine, either having started it within the past 3 months or having had their dose adjusted within the past 3 months (for example, reducing the dose with a goal of moving to a different medication)
- People who are currently experiencing significant sleep disturbances, as measured by a standard sleep quality assessment (confirm with trial site)
- People who are able to read and understand English
- People who own an Android or iOS smartphone
- People who are at least 18 years of age
Who may not be able to join:
- People who are currently experiencing symptoms of psychosis
- People who are currently having active thoughts of suicide
- People with severe visual impairment
- People who are currently using benzodiazepines (a type of sedative or anti-anxiety medication)
- People who currently have a severe substance use disorder involving a substance other than opioids, meaning they meet more than 5 diagnostic criteria for another substance use disorder (confirm with trial site)
- People who are currently pregnant or in the period shortly after giving birth
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Allison K Wilkerson, Ph.D., Medical University of South Carolina
Phone: 843-792-4636
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Enrollment feasibility/acceptability benchmark of at least 30 persons completing entire study period - Enrollment and retention percentages; Protocol adherence feasibility/acceptability benchmarks of participants completing modules and sleep diaries each week - Engagement; mHealth App Usability Questionnaire
Can't join this trial?
Data last synced from ClinicalTrials.gov: 22 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.